Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes
BACKGROUND: Macrolide antibiotics are commonly used to treat pneumonia despite increasing antimicrobial resistance. Evidence suggests that macrolides may also decrease mortality in severe sepsis via immunomodulatory properties.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2013/652512 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547001670041600 |
|---|---|
| author | Wendy I Sligl Holly Hoang Dean T Eurich Atul Malhotra Thomas J Marrie Sumit R Majumdar |
| author_facet | Wendy I Sligl Holly Hoang Dean T Eurich Atul Malhotra Thomas J Marrie Sumit R Majumdar |
| author_sort | Wendy I Sligl |
| collection | DOAJ |
| description | BACKGROUND: Macrolide antibiotics are commonly used to treat pneumonia despite increasing antimicrobial resistance. Evidence suggests that macrolides may also decrease mortality in severe sepsis via immunomodulatory properties. |
| format | Article |
| id | doaj-art-392f6bf8358d477a8b7669b89478a7b2 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-392f6bf8358d477a8b7669b89478a7b22025-02-03T06:46:20ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322013-01-01244e107e11210.1155/2013/652512Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and OutcomesWendy I Sligl0Holly Hoang1Dean T Eurich2Atul Malhotra3Thomas J Marrie4Sumit R Majumdar5Divisions of Critical Care Medicine and Infectious Diseases, University of Alberta, Edmonton, Alberta, CanadaDivision of Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CanadaDepartment of Public Health Sciences, School of Public Health, University of Alberta, Edmonton, Alberta, CanadaDepartment of Medicine, Faculty of Medicine, Harvard University, Boston, Massachusetts, USADepartment of Medicine, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Macrolide antibiotics are commonly used to treat pneumonia despite increasing antimicrobial resistance. Evidence suggests that macrolides may also decrease mortality in severe sepsis via immunomodulatory properties.http://dx.doi.org/10.1155/2013/652512 |
| spellingShingle | Wendy I Sligl Holly Hoang Dean T Eurich Atul Malhotra Thomas J Marrie Sumit R Majumdar Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes |
| title_full | Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes |
| title_fullStr | Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes |
| title_full_unstemmed | Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes |
| title_short | Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes |
| title_sort | macrolide use in the treatment of critically ill patients with pneumonia incidence correlates timing and outcomes |
| url | http://dx.doi.org/10.1155/2013/652512 |
| work_keys_str_mv | AT wendyisligl macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes AT hollyhoang macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes AT deanteurich macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes AT atulmalhotra macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes AT thomasjmarrie macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes AT sumitrmajumdar macrolideuseinthetreatmentofcriticallyillpatientswithpneumoniaincidencecorrelatestimingandoutcomes |